Needham & Company LLC Reaffirms Buy Rating for LivaNova (NASDAQ:LIVN)

Needham & Company LLC reissued their buy rating on shares of LivaNova (NASDAQ:LIVN) in a report published on Monday morning,Benzinga reports. The brokerage currently has a $75.00 target price on the stock.

Several other research firms have also weighed in on LIVN. The Goldman Sachs Group started coverage on LivaNova in a research note on Friday, October 4th. They issued a “buy” rating and a $65.00 price objective on the stock. Mizuho lowered their price objective on LivaNova from $80.00 to $70.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. StockNews.com lowered LivaNova from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 16th. Baird R W upgraded LivaNova from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, Robert W. Baird upped their price objective on LivaNova from $66.00 to $72.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, LivaNova presently has an average rating of “Buy” and a consensus price target of $69.17.

LivaNova Trading Up 0.8 %

LivaNova stock opened at $51.75 on Monday. LivaNova has a 12 month low of $42.75 and a 12 month high of $64.47. The stock has a market cap of $2.81 billion, a price-to-earnings ratio of 123.21 and a beta of 1.01. The business has a 50 day moving average price of $52.19 and a two-hundred day moving average price of $52.38. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46.

Institutional Investors Weigh In On LivaNova

Large investors have recently bought and sold shares of the business. Fifth Third Bancorp grew its position in LivaNova by 97.1% during the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after acquiring an additional 332 shares during the last quarter. Hexagon Capital Partners LLC boosted its position in LivaNova by 117.8% in the 2nd quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock valued at $37,000 after buying an additional 370 shares during the last quarter. Lazard Asset Management LLC bought a new position in LivaNova in the 1st quarter valued at $84,000. Canada Pension Plan Investment Board bought a new position in LivaNova in the 2nd quarter valued at $88,000. Finally, Acadian Asset Management LLC bought a new position in LivaNova in the 1st quarter valued at $94,000. 97.64% of the stock is currently owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.